中化巖土(002542.SZ):子公司中標8275.29萬元成都健康醫學中心—環湖路醫學城段改造工程施工/標段項目
格隆匯 2 月 4日丨中化巖土(002542.SZ)公佈,2021年2月4日,公司的全資子公司北京場道市政工程集團有限公司(“北京場道”)收到《中標通知書》,確認北京場道中標成都健康醫學中心(未來醫學城)—環湖路醫學城段改造工程施工/標段項目,招標人成都醫療健康投資集團有限公司(“成都醫投”)為公司控股股東成都興城投資集團有限公司(“成都興城集團”)的全資子公司,與公司具有關聯關係,此次交易構成關聯交易。
工程名稱:成都健康醫學中心(未來醫學城)—環湖路醫學城段改造工程施工/標段;建設規模:道路全長約1185米,建設範圍包括道路、排水、給水、再生水、電力通道、通信通道、涵洞、照明、交通及景觀綠化等;中標價:8275.29萬元。
上述中標金額佔公司2019年度經審計營業收入的2.02%,上述交易的內容屬於北京場道日常的經營行為,不會對公司獨立性產生影響。該項目簽訂正式合同且順利實施後,將對公司未來年度經營業績產生積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.